Doctors Note Logo

Published on: 7/21/2026

Can topical steroids thin the skin?

Yes, topical steroids can thin the skin, particularly with prolonged or high-potency use. This side effect, known as skin atrophy, occurs because steroids slow down collagen production and reduce skin cell turnover. Thinner skin may appear fragile, translucent, or bruise more easily, and blood vessels underneath can become more visible. The risk increases with stronger steroids, longer treatment duration, and application to sensitive areas like the face, groin, or skin folds.

If you're using topical steroids and noticing changes in your skin, or if you're unsure whether your symptoms warrant continued treatment, it's important to get clarity before problems worsen. Skin changes can signal many different conditions, and understanding the root cause helps you make informed decisions about your care. Take a free, instant, online symptom check to better understand what may be going on and to help you confidently navigate your next steps.

Reviewed for medical accuracy: 07/20/2026

answer background

Explanation

Topical steroids are creams or ointments applied to the skin to reduce inflammation and irritation. However, according to the medical literature, using these steroids can cause the skin to become thinner, a condition known as skin atrophy.

How it Happens:

  1. Skin Atrophy: The skin becomes thinner because the steroids affect the skin's structure and strength.
  2. Barrier Impairment: The skin's ability to protect against germs and injuries can be reduced.

Important Points:

  • This thinning is more likely if the steroids are used for a long time or in high amounts.
  • Different people may experience this side effect differently.

If you are using topical steroids and experiencing unusual skin changes or other concerning symptoms, consider using a free symptom checker to help assess your condition, and follow your doctor's instructions to minimize the risk of skin thinning.

(References)

  • Barnes L, Kaya G, & Rollason V. (2015). Topical corticosteroid-induced skin atrophy. Drug safety, 25862024.

  • Kolbe L, Kligman AM, Schreiner V, & Stoudemayer T. (2001). Corticosteroid-induced atrophy and barrier impairment .... Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 11393207.

  • Kolbe L, Stoudemayer T, & Kligman AM. (1998). Assessment of the atrophogenicity of corticosteroids to .... Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 27332683.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.